Soybean oil - Generic Drug Details

What are the generic drug sources for soybean oil and what is the scope of freedom to operate?

Soybean oil is the generic ingredient in twelve branded drugs marketed by Fresenius, Hospira, B Braun, Alpha Thera, and Baxter Hlthcare, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for soybean oil. Five suppliers are listed for this compound.

Summary for soybean oil

US Patents:	0
Tradenames:	12
Applicants:	5
NDAs:	12
Drug Master File Entries:	11
Finished Product Suppliers / Packagers:	5
Clinical Trials:	76
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for soybean oil
What excipients (inactive ingredients) are in soybean oil?	soybean oil excipients list
DailyMed Link:	soybean oil at DailyMed

Recent Clinical Trials for soybean oil

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Anhui Medical University	NA
Scotiaderm	NA
The Salvation Army Toronto Grace Health Centre	NA

See all soybean oil clinical trials

Pharmacology for soybean oil

Drug Class

Lipid Emulsion

Anatomical Therapeutic Chemical (ATC) Classes for soybean oil

A06AG	Enemas
A06A	DRUGS FOR CONSTIPATION
A06	DRUGS FOR CONSTIPATION
A	Alimentary tract and metabolism

US Patents and Regulatory Information for soybean oil

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	NUTRILIPID 10%	soybean oil	INJECTABLE;INJECTION	019531-001	May 28, 1993		DISCN	Yes	No
Fresenius	INTRALIPID 10%	soybean oil	INJECTABLE;INJECTION	017643-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Baxter Hlthcare	TRAVAMULSION 20%	soybean oil	INJECTABLE;INJECTION	018758-001	Feb 15, 1983		DISCN	No	No
B Braun	NUTRILIPID 20%	soybean oil	INJECTABLE;INJECTION	019531-002	May 28, 1993	AP	RX	Yes	Yes
Alpha Thera	SOYACAL 10%	soybean oil	INJECTABLE;INJECTION	018465-001	Jun 29, 1983		DISCN	No	No
Fresenius	INTRALIPID 30%	soybean oil	INJECTABLE;INJECTION	019942-001	Dec 30, 1993		RX	Yes	Yes
Baxter Hlthcare	TRAVAMULSION 10%	soybean oil	INJECTABLE;INJECTION	018660-001	Feb 26, 1982		DISCN	No	No

Soybean oil Market Analysis and Financial Projection

Last updated: February 15, 2026

What Are the Market Dynamics for Soybean Oil in the Pharmaceutical Sector?

Soybean oil, primarily known for its food and industrial applications, plays a limited yet growing role in the pharmaceutical industry. Its use as an excipient, carrier, or raw material for drug formulation and manufacturing is expanding, driven by changing health trends and production innovations. The global market for soybean oil is influenced chiefly by agricultural supply, commodity prices, regulatory frameworks, and evolving consumer health preferences.

The agricultural production of soybean oil reached 59 million metric tons in 2022, with the United States, Brazil, and Argentina leading as top producers[1]. Market dynamics are shaped by commodity price fluctuations, weather-related supply disruptions, and geopolitical factors impacting trade flows. Prices ranged from $0.50 to $0.85 per pound in 2022, reflecting volatility linked to supply chain disruptions and global demand shifts.

In the pharmaceutical niche, soybean oil’s role is modest but growing, driven by bio-based excipients, lipid-based drug delivery systems, and as a component in nutraceuticals. The total value of soybean oil used for pharmaceutical applications is estimated at a few hundred million dollars globally, a small fraction of the overall soybean oil market (~$35 billion in 2022[2]).

How Do Market Forces Influence Future Growth and Pricing?

Supply and Demand Factors
Soybean oil prices are sensitive to agricultural yields and planting acreages. Weather events like droughts or floods can constrain supply, pushing prices higher. Market demand from food processors, biodiesel producers, and pharma will influence prices.

Trade Policies and Tariffs
Tariffs and trade agreements affect the export and import costs of soybean oil. The U.S.-China trade tensions, for instance, led to tariffs impacting soybean exports in recent years, which in turn affected global prices[3]. Developing countries reduce reliance on imports through local cultivation, impacting supply chains and prices.

Regulatory and Innovation Trends
In pharmaceuticals, regulatory approval processes for soy-based excipients and delivery systems influence market entry. The adoption of biologics and lipid-based formulations increases demand for suitable lipid sources like soybean oil. Innovation around refining technologies increases purity and functionality, potentially adding value.

Consumer Health and Sustainability Trends
Increased awareness regarding trans fats and saturated fats has shifted demand toward non-hydrogenated oils like soybean oil, regarded as healthier dietary fats. Environmental concerns about soybean cultivation—deforestation and bio-diversity impacts—pressure producers to adopt sustainable practices. Certifications and traceability initiatives are increasingly necessary for market acceptance.

What Is the Financial Trajectory for Soybean Oil in Pharmaceutical Applications?

Market Size and Growth Rate
Though the pharmaceutical application is a small segment, growth is expected to accelerate at a compound annual growth rate (CAGR) of approximately 4-6% over the next five years[4]. This reflects broader trends in lipid-based drug carriers and the rising use of plant-derived excipients.

Revenue Projections
Global pharmaceutical soybean oil sales are projected to reach approximately $0.7-$1 billion by 2028, up from roughly $0.5 billion in 2022[5]. Growth is driven by increased adoption of soybean oil in lipid nanoparticles, emulsions, and as a carrier for bioactive compounds.

Cost Structures and Margins
Raw material costs for soybean oil are influenced by commodity prices, constituting roughly 50-60% of production costs for pharma-grade oils. Value-added processes—refining, purification, and formulation—add margins, with potential profit margins in pharma applications ranging from 10-20% depending on scale and process efficiency.

Key Players and Market Competition
Major soybean oil producers include Archer Daniels Midland, Cargill, Bunge, and Wilmar International. Their engagement in pharmaceutical segments involves partnerships with biopharmaceutical firms and specialty chemical manufacturers. Competitive advantage hinges on product purity, traceability, and sustainability credentials.

How Are Technological and Policy Developments Shaping the Market?

Refining and Purification Technologies
Advances in extraction methods, such as supercritical CO2 extraction, improve purity while reducing contaminants. Nanoparticle compatibility enhances lipid-based drug delivery systems.

Bio-sourcing and Supply Chain Transparency
Traceability initiatives driven by blockchain technology help meet regulatory and consumer transparency demands, positioning soybean oil as a sustainable ingredient.

Regulatory Frameworks
The U.S. Food and Drug Administration (FDA) classifies soybean oil as Generally Recognized As Safe (GRAS) for certain pharmaceutical uses. International standards like USP monographs guide quality and safety requirements.

Intellectual Property and Patent Landscape
Patent filings around lipid formulations and soybean oil-derived excipients have increased, indicating ongoing R&D investments. Patents focus on novel lipid structures, purification techniques, and delivery platforms.

What Are the Implications for Investors and R&D Stakeholders?

Investors should monitor commodity price trends, trade policies, and regulatory changes affecting soybean oil production and purity standards. R&D efforts should focus on improving extraction processes and developing high-purity, bio-sustainable soybean oil derivatives optimized for pharmaceutical use. Partnerships between agricultural firms and biotech entities will be crucial for innovation.

Key Takeaways

• The soybean oil market is heavily influenced by agricultural supply, trade policy, and renewable energy trends.
• Its role in pharmaceuticals is niche but expanding, with an anticipated CAGR of 4-6%.
• Future growth depends on advancements in extraction, purification, and delivery system technologies, alongside sustainability initiatives.
• Prices fluctuate with commodity markets; supply chain resilience remains critical.
• Regulatory clarity and innovation in lipid formulations will drive adoption.

FAQs

1. What is the scale of soybean oil use specifically in pharmaceuticals?
Less than 1% of total soybean oil production, estimated at a few hundred million dollars globally.

2. How do trade disputes impact soybean oil availability for pharma?
Trade tariffs and restrictions can increase costs and limit access, influencing supply chains and pricing stability.

3. Are there regulatory hurdles for soybean oil-based drug carriers?
Yes, approval requires demonstrating safety, purity, and efficacy, with standards set by agencies like FDA and EMA.

4. Will sustainability concerns affect soybean oil sourcing?
Yes. Certifications and traceability are increasingly necessary for market access and stakeholder acceptance.

5. What technological innovations are most promising for pharmaceutical soybean oil?
Refinement methods that improve purity, nanoparticle formulation techniques, and blockchain for supply chain transparency.

---

Sources
[1] USDA, "Oil Crops: World Markets and Trade," 2022.
[2] Statista, "Global Soybean Oil Market Size," 2022.
[3] WTO, "Trade Policy Review," 2021.
[4] MarketsandMarkets, "Lipid-Based Drug Delivery Market," 2022.
[5] Grand View Research, "Plant-Based Lipids Market Analysis," 2022.